Jane Street’s NRX Pharmaceuticals NRXP Stock Holding History

Jane Street’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$94K	Buy	44,152 +6,087	+16%	+$12.3K	﹤0.01%	10682
2025 Q4	$103K	Sell	38,065 -35,334	-48%	-$94.8K	﹤0.01%	10170
2025 Q3	$242K	Buy	+73,399	New	+$210K	﹤0.01%	9317
2024 Q2	–	Sell	-2,769	Closed	-$13.1K	–	9935
2024 Q1	$13.1K	Buy	+2,769	New	+$12.8K	﹤0.01%	8945
2023 Q3	–	Sell	-1,505	Closed	-$7.28K	–	9138
2023 Q2	$7.28K	Buy	+1,505	New	+$9.05K	﹤0.01%	8469
2022 Q1	–	Sell	-5,373	Closed	-$257K	–	10799
2021 Q4	$257K	Sell	5,373 -2,330	-30%	-$168K	﹤0.01%	8443
2021 Q3	$714K	Buy	+7,703	New	+$1M	﹤0.01%	6606
2021 Q2	–	Sell	-715	Closed	-$253K	–	10202
2021 Q1	$253K	Buy	+715	New	+$259K	﹤0.01%	7933

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's NRXP Position: Q1 2026 in Review

Jane Street increased its NRX Pharmaceuticals (NRXP) stake by 16% in Q1 2026, buying an estimated $12.3K and bringing the position to 44,152 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #10682.

Jane Street first reported a position in NRXP in Q1 2021 and has held it in 8 quarters since. The position peaked at $714K in Q3 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

Jane Street held 44,152 shares of NRX Pharmaceuticals worth $94K as of Q1 2026.
Jane Street bought 6,087 NRX Pharmaceuticals shares in Q1 2026, an estimated $12.3K.
NRX Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10682 holding.
Jane Street first reported a position in NRX Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
Jane Street's NRX Pharmaceuticals position peaked at $714K in Q3 2021.
33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.